Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 0 Study in Subjects With Well Controlled Celiac Disease to Assess the Effects of Gluten Digestion With ALV003 (a Protease Enzyme) in Vitro

NCT00859391 is registered in ClinicalTrials.gov with Alvine Pharmaceuticals Inc. as lead sponsor.

NCT NCT00859391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00859391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 0 Study in Subjects With Well Controlled Celiac Disease to Assess the Effects of Gluten Digestion With ALV003 (a Protease Enzyme) in Vitro
Lead sponsor
Alvine Pharmaceuticals Inc.
Phase
Observational
Overall status
Completed
Start date
May 31, 2008
Completion date
June 30, 2008
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease